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Background
We aimed to establish levels of consumer involvement
in randomised controlled trials (RCTs), meta-analyses
and other studies carried out by the MRC Clinical Trials
Unit across the range of research programs, predomi-
nantly in cancer and HIV.
Methods
Staff responsible for studies included in a Unit Progress
Report (MRC CTU, April 2009) were asked to complete
a questionnaire survey regarding consumer involvement.
This was defined as active involvement of consumers as
partners in the research process and not as subjects of
that research. The electronic questionnaires combined
open and closed questions, intended to capture quanti-
tative and qualitative information on whether studies
had involved consumers; types of activities undertaken;
recruitment and support; advantages and disadvantages
of involvement and its perceived impact on aspects of
the research.
Results
Between October 2009 and April 2010, 138 completed
questionnaires (86%) were returned. Studies had been
conducted over a 20 year period from 1989, and around
half were in cancer; 30% in HIV and 20% were in other
disease areas including arthritis, tuberculosis and blood
transfusion medicine. Forty-three studies (31%) had
some consumer involvement, most commonly as mem-
bers of trial management groups (TMG) [88%]. A num-
ber of positive impacts on both the research and the
researcher were identified. Researchers generally felt
involvement was worthwhile and some felt that consu-
mer involvement had improved the credibility of the
research. Benefits in design and quality, trial
recruitment, dissemination and decision making were
also perceived. Researchers felt they learned from consu-
mer involvement, albeit that there were some barriers.
Additional results will be presented.
Conclusions
Whilst most researchers identified benefits of involving
consumers, most of studies included in the survey had
no involvement. Information from this survey will
inform the development of a unit policy on consumer
involvement, to guide future research conducted within
the MRC Clinical Trials Unit.
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